{
    "bcoid": "GLY_000737",
    "title": "Glycan Biomarkers (Biomarker Database)",
    "description": "The Glycan Biomarkers dataset contains glycan biomarker information,  including cross-mapped GlyTouCan ...",
    "filename": "glycan_biomarkers.csv",
    "filetype": "csv",
    "categories": {
        "molecule": [
            "Glycan"
        ],
        "tag": [
            "Glycan Biomarker (BiomarkerDB)"
        ],
        "file_type": [
            "csv"
        ],
        "status": [
            "Reviewed"
        ],
        "scope": [
            "internal"
        ],
        "species": [
            "Drosophila melanogaster",
            "Homo sapiens",
            "Mus musculus",
            "Sus scrofa",
            "Rattus",
            "Rattus norvegicus",
            "Severe acute respiratory syndrome coronavirus 2",
            "Saccharomyces cerevisiae",
            "Dictyostelium discoideum",
            "Hepacivirus C"
        ]
    },
    "minitable": {
        "content": [
            [
                "G06110VR...",
                "A0245..."
            ],
            [
                "G06110VR...",
                "A0245..."
            ]
        ],
        "headers": [
            "glytoucan_ac...",
            "biomarker_id..."
        ],
        "colwidth": [
            "40%",
            "20%"
        ]
    },
    "sampledata": {
        "type": "table",
        "data": [
            [
                {
                    "type": "string",
                    "label": "glytoucan_ac"
                },
                {
                    "type": "string",
                    "label": "biomarker_id"
                },
                {
                    "type": "string",
                    "label": "assessed_biomarker_entity"
                },
                {
                    "type": "string",
                    "label": "biomarker"
                },
                {
                    "type": "string",
                    "label": "best_biomarker_type"
                },
                {
                    "type": "string",
                    "label": "loinc_code"
                },
                {
                    "type": "string",
                    "label": "notes"
                },
                {
                    "type": "string",
                    "label": "literature_evidence"
                },
                {
                    "type": "string",
                    "label": "anatomical_entity"
                },
                {
                    "type": "string",
                    "label": "uberon_id"
                },
                {
                    "type": "string",
                    "label": "do_id"
                },
                {
                    "type": "string",
                    "label": "do_name"
                },
                {
                    "type": "string",
                    "label": "assessed_entity_type"
                },
                {
                    "type": "string",
                    "label": "xref_key"
                },
                {
                    "type": "string",
                    "label": "xref_id"
                },
                {
                    "type": "string",
                    "label": "src_xref_key"
                },
                {
                    "type": "string",
                    "label": "src_xref_id"
                }
            ],
            [
                "G06110VR",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G06110VR",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G06110VR",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G23453IV",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G23453IV",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G23453IV",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G39188ZX",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G39188ZX",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G39188ZX",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G33609NS",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G33609NS",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G33609NS",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G81295CK",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G81295CK",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G81295CK",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G31936TA",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G31936TA",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G31936TA",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G82119TF",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G82119TF",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G82119TF",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G50045TK",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G50045TK",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G50045TK",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G10256JP",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G10256JP",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G10256JP",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G23432EQ",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G23432EQ",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G23432EQ",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G64527OM",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G64527OM",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G64527OM",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G12313PD",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G12313PD",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G12313PD",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G23863VK",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G23863VK",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G23863VK",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G70101JE",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G70101JE",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G70101JE",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G06356OH",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G06356OH",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G06356OH",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G44215PV",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G44215PV",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G44215PV",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G24835MQ",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G24835MQ",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G24835MQ",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G20425TQ",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G20425TQ",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G20425TQ",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G39619TI",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G39619TI",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G39619TI",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G84452RH",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G84452RH",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G84452RH",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G72797UR",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G72797UR",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G72797UR",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G48414YA",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G48414YA",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G48414YA",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G75983OB",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G75983OB",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G75983OB",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G22625SJ",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G22625SJ",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G22625SJ",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G95977AE",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G95977AE",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G95977AE",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G66163OV",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G66163OV",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G66163OV",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G02030ZB",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G02030ZB",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G02030ZB",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G59536GA",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_biomarkerdb",
                "A0245",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G59536GA",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31721442",
                "glycan_xref_biomarkerdb",
                "A0245"
            ],
            [
                "G59536GA",
                "A0245",
                "Glyco-typer 50 N-glycan liver disease panel",
                "MALDI-MS measured N-glycans",
                "monitoring",
                "",
                "A profile (panel) of N-linked glycans (identified based on theoretical mass value), covalently attached to specific immuno-captured serum proteins, believed to act as liver disease biomarkers. The panel provides compositional and quantitative N-glycan information. Assayed components of the panel may be used to compare disease-related glycosylation changes of the N-glycan elements (quantities, compositions) in the studied cirrhosis, HCC, and transplant cohort populations.",
                "Quantities (measured by MALDI-MS Glyco-typer technology) of 44 N-glycans covalently attached to serum glycoproteins Alpha-1-antitrypsin, Haptoglobin, Serotransferrin, Alpha-1-acid glycoprotein 1, Low molecular weight kininogen, Immunoglobulin G, and Hemopexin in cirrhosis, HCC, and transplant cohorts. Quantities (measured by MALDI-MS Glyco-typer technology) of an additional 6 N-glycans covalently attached to serum glycoproteins Low molecular weight kininogen and Immunoglobulin G in the cirrhosis, HCC, and transplant cohorts. [PMID: 31721442, PMID: 31177770] Hex5HexNAc2 [Glytoucan ID: G06110VR], Hex4HexNAc3 [Glytoucan ID: G23453IV], Hex6HexNAc2 [Glytoucan ID: G39188ZX], Hex5HexNAc3 [Glytoucan ID: G33609NS], Hex4HexNAc4 [Glytoucan ID: G81295CK], Hex3HexNAc5 [Glytoucan ID: G31936TA], Hex3HexNAc5 (Hydrogen) [Glytoucan ID: G31936TA], Hex5dHex1HexNAc3 [Glytoucan ID: G82119TF], Hex3HexNAc4NeuGc1 [Glytoucan ID: G49347SB], Hex5HexNAc4 [Glytoucan ID: G50045TK], Hex3dHex1HexNAc5 [Glytoucan ID: G10256JP], Hex4HexNAc5 [Glytoucan ID: G23432EQ], Hex8HexNAc2 [Glytoucan ID: G64527OM], Hex5dHex2HexNAc3 [Glytoucan ID: G12313PD], Hex5dHex1HexNAc4 [Glytoucan ID: G23863VK], Hex9HexNAc2 [Glytoucan ID: G70101JE], Hex5HexNAc4NeuAc1 [Glytoucan ID: G06356OH], Hex5dHex2HexNAc4 [Glytoucan ID: G44215PV], Hex5HexNAc4NeuAc1 + 2Na [Glytoucan ID: G06356OH], Hex4HexNAc5NeuAc1 [Glytoucan ID: G24835MQ], Hex6HexNAc5 [Glytoucan ID: G20425TQ], Hex5dHex2HexNAc4 + 2Na + SO4 [Glytoucan ID: G44215PV], Hex5HexNAc6 [Glytoucan ID: G39619TI], Hex5dHex1HexNAc4NeuAc1 + 2Na [Glytoucan ID: G84452RH], Hex6dHex1HexNAc5 [Glytoucan ID: G72797UR], Unknown Glycan 1 [Glytoucan ID: unassigned], Hex5HexNAc4NeuAc2 [Glytoucan ID: G48414YA], Hex5HexNAc4NeuAc2 + 2Na [Glytoucan ID: G48414YA], Hex5dHex2HexNAc4NeuAc1 + 2Na [Glytoucan ID: G75983OB], Hex6dHex1HexNAc5 + 1SO4 + 2Na [Glytoucan ID: G72797UR], Hex5HexNAc4NeuAc2 + 3Na [Glytoucan ID: G48414YA], Hex5dHex3HexNAc5 [Glytoucan ID: G22625SJ], Hex4dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G95977AE], Hex6dHex2HexNAc5 [Glytoucan ID: G66163OV], Hex5dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G02030ZB], Hex6HexNAc5NeuAc1 + 2Na [Glytoucan ID: G59536GA], Hex6dHex1HexNAc6 [Glytoucan ID: G70375MX], Hex7HexNAc6 [Glytoucan ID: G47012YE], Hex9HexNAc3NeuAc1 + 2Na [Glytoucan ID: G96747WW], Hex5dHex1HexNAc4NeuAc2 + 3Na [Glytoucan ID: G22310AV], Hex6dHex1HexNAc5NeuAc1 + 2Na [Glytoucan ID: G81263BG], Hex7dHex1HexNAc6 [Glytoucan ID: G90093AU], Hex6dHex2HexNAc5NeuAc1 + 2Na [Glytoucan ID: G86795LJ], Hex6dHex1HexNAc6NeuAc1 + 2Na [Glytoucan ID: G31596VW]; Compositions and IDs of additional measured N-glycans attached to IgG, LMWK: Hex10HexNAc2 [Glytoucan ID: G40066BA], Hex3dHex1HexNAc4 [Glytoucan ID: G49874UX], Hex4dHex1HexNAc4 [Glytoucan ID: G46687AB], Hex4dHex1HexNAc5 [Glytoucan ID: G03382KH], Hex5dHex1HexNAc5 [Glytoucan ID: G91636VS], Hex5HexNAc5 [Glytoucan ID: G79568CQ]",
                "blood",
                "0000178",
                "3571",
                "DOID:3571 / Liver Cancer",
                "glycan",
                "glycan_xref_pubmed",
                "31177770",
                "glycan_xref_biomarkerdb",
                "A0245"
            ]
        ]
    },
    "readme": "Name\n   - Glycan Biomarkers (Biomarker Database)\n\nVersion\n   - v-2.2.1\n\nCreated on\n  - 2023-03-14T20:00:08.127Z\n\nModified on\n   - 2023-03-14T20:07:25.567Z\n\nCreated by\n   - Jeet Vora [jeetvora@gwu.edu], Karina Martinez [karinamartinez@gwu.edu], Robel Kahsay [rykahsay@gwu.edu], Dan Lyman [danlyman@gwu.edu], Jingyue Wu [jingyue.wu@email.gwu.edu]\n\nAuthors\n   - \n\nChecksum\n   - \n\nUsability Domain\n   - The Glycan Biomarkers dataset contains glycan biomarker information,  including cross-mapped GlyTouCan accessions, assessed biomarker entity, biomarker type, specimen type, LOINC code, disease name, and source evidence from the biomarker portal (https://data.oncomx.org/allbiomarkers). If you use this dataset, please provide proper attribution to OncoMX and GlyGen. Cite: PMID:32142370, PMID:34015823, and PMID:31616925.\n\nDescription Domain\n   Keywords\n   - biomarker\n   - cancer\n\n   Pipeline Steps\n   - Step-1: \n\nExecution Domain\n   Scripts   - https://github.com/glygener/glygen-backend-integration/blob/master/dataset-maker/\n\n\n   Software Prerequisites\n      Name: Python\n      Version: 2.7.5\n      URI: https://www.python.org/download/releases/2.7.5/\n\nI/O Domain\n   Input Subdomain\n      Name: glycan_masterlist.csv\n      URI: https:/data.glygen.org/ln2releases/data/v-2.2.1/reviewed/glycan_masterlist.csv\n      Name: doid2uberonid_mapping_v5.csv\n      URI: https:/data.glygen.org/ln2releases/data/v-2.2.1/misc/doid2uberonid_mapping_v5.csv\n      Name: sample_mapping.csv\n      URI: https:/data.glygen.org/ln2releases/data/v-2.2.1/misc/sample_mapping.csv\n      Name: allbiomarkers-all.csv\n      URI: https:/data.glygen.org/ln2downloads/biomarkerdb/2023_08_11/allbiomarkers-all.csv\n   Output Subdomain\n      Name: glycan_biomarkers.csv\n      URI: https:/data.glygen.org/ln2releases/data/v-2.2.1/reviewed/glycan_biomarkers.csv\n      Name: glycan_biomarkers.stat.csv\n      URI: https:/data.glygen.org/ln2releases/data/v-2.2.1/reviewed/glycan_biomarkers.stat.csv\n\nFields\n      Name: \"glytoucan_ac\"\n     Description: \"Unique accession assigned to the registered glycan structure in GlyTouCan database\"\n      Unique Values: \"74\"\n      Name: \"biomarker_id\"\n     Description: \"\"\n      Unique Values: \"31\"\n      Name: \"assessed_biomarker_entity\"\n     Description: \"\"\n      Unique Values: \"31\"\n      Name: \"biomarker\"\n     Description: \"\"\n      Unique Values: \"31\"\n      Name: \"best_biomarker_type\"\n     Description: \"\"\n      Unique Values: \"4\"\n      Name: \"loinc_code\"\n     Description: \"\"\n      Unique Values: \"1\"\n      Name: \"notes\"\n     Description: \"Notes\"\n      Unique Values: \"11\"\n      Name: \"literature_evidence\"\n     Description: \"\"\n      Unique Values: \"18\"\n      Name: \"anatomical_entity\"\n     Description: \"\"\n      Unique Values: \"3\"\n      Name: \"uberon_id\"\n     Description: \"\"\n      Unique Values: \"3\"\n      Name: \"do_id\"\n     Description: \"Disease Ontology identifier\"\n      Unique Values: \"9\"\n      Name: \"do_name\"\n     Description: \"Disease Ontology term or name for the disease assigned to the Disease Ontology identifier\"\n      Unique Values: \"9\"\n      Name: \"assessed_entity_type\"\n     Description: \"\"\n      Unique Values: \"2\"\n      Name: \"xref_key\"\n     Description: \"Source key associated to the  xref_id\"\n      Unique Values: \"2\"\n      Name: \"xref_id\"\n     Description: \"ID of the X-ref\"\n      Unique Values: \"49\"\n      Name: \"src_xref_key\"\n     Description: \"Source Xref  key\"\n      Unique Values: \"1\"\n      Name: \"src_xref_id\"\n     Description: \"Source X-ref ID\"\n      Unique Values: \"31\"",
    "downloadurl": "/ln2data/releases/data/v-2.2.1/reviewed/glycan_biomarkers.csv"
}